RSV
RSV (respiratory syncytial virus) is a virus that causes respiratory tract infections.
Products for RSV
- Cat.No. Product Name Information
- GC62750 (S)-Enzaplatovir (S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77).
- GC32113 Ac-CoA Synthase Inhibitor1 Ac-CoA Synthase Inhibitor1 is a potent, reversible acetate-dependent acetyl-CoA synthetase 2 (ACSS2) inhibitor with an IC50 of 0.6 ?M.
- GC32070 ALS-8112 ALS-8112 is a potent and selective respiratory syncytial virus (RSV) polymerase inhibitor.
- GN10484 Amentoflavone
- GC62955 Enzaplatovir Enzaplatovir (BTA-C585) is an orally bioavailable fusion inhibitor for respiratory syncytial virus (RSV) infection.
- GC43730 Ganglioside GM1 Asialo Mixture Ganglioside GM1 asialo is a component of cellular lipid rafts and can be formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase.
- GC49165 GS-441524 tris-isobutyryl ester A prodrug form of GS-441524
- GC32297 JNJ-678 (JNJ-53718678) JNJ-678 (JNJ-53718678) (JNJ-678) is a novel fusion protein inhibitor.
- GC32087 Lumicitabine (ALS-008176) Lumicitabine (ALS-008176) (ALS-008176) is an inhibitor of the respiratory syncytial virus (RSV) polymerase.
- GC68286 Motavizumab
-
GC69563
Nirsevimab
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region that extends its half-life. Nirsevimab has an affinity for RSV-B, with a Kd value of 1.5 nM. Nirsevimab can be used in RSV research.
- GC68300 Palivizumab
- GC32300 PC786 PC786 is an inhaled respiratory syncytial virus (RSV) L protein polymerase inhibitor.
- GC40189 Pentaacetylquercetin Pentaacetylquercetin could interact with F-protein with lower binding energy and better stability to block viral adhesion.
- GC32069 Presatovir (GS-5806) Presatovir (GS-5806) (GS-5806) is an orally bioavailable RSV fusion inhibitor with a mean EC50 value of 0.43 nM.
- GC32340 RD3-0028 RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.
-
GC11518
Ribavirin
Antiviral guanosine ribonucleoside analog
- GC49395 Ribavirin-13C5 An internal standard for the quantification of ribavirin
- GC16347 Roflumilast A PDE4 inhibitor
- GC32213 RSV-IN-1 RSV-IN-1 is a human respiratory syncytical virus (hRSV) inhibitor, with an IC50 of 0.11 μM.
- GC67684 RSV-IN-7
- GC19313 RSV604 RSV604 is a novel inhibitor of respiratory syncytial virus replication(EC50=0.86 uM); a putative RSV nucleoprotein(N) inhibitor in phase 2 clinical trials.
- GC37565 RSV604 R enantiomer RSV604 R enantiomer is the R-enantiomer of RSV604.
- GC37566 RSV604 racemate RSV604 (A-60444) racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer.
- GC48973 Sekikaic Acid A lichen metabolite with diverse biological activities
- GC62216 Sisunatovir Sisunatovir (RV521), an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4 nM and 1.0 nM, respectively.
- GC62217 Sisunatovir hydrochloride Sisunatovir (RV521) hydrochloride, an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4?nM and 1.0?nM, respectively.
-
GC69974
Suptavumab
Suptavumab (REGN2222) is a human monoclonal antibody that can bind and block the conserved epitopes on both RSV A and B subtypes. Suptavumab can be used for research on RSV infection.
-
GC17373
TMC353121
TMC353121 is a RSV fusion inhibitor.
- GC11893 VP-14637 inhibitor of RSV
- GC38582 Ziresovir Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor.